IGF-II Reverses Mitochondrial Dysfunction in Aging Rats
Author Information
Author(s): Garcia-Fernandez Maria, Sierra Inma, Puche Juan E, Guerra Lucia, Castilla-Cortazar Inma
Primary Institution: Department of Physiology, School of Medicine, University of Málaga
Hypothesis
The cytoprotective actions of IGF-II therapy are mediated by mitochondrial protection.
Conclusion
IGF-II therapy improves mitochondrial function in aging rats, leading to increased ATP production and reduced oxidative damage.
Supporting Evidence
- IGF-II therapy corrected mitochondrial dysfunction parameters in aging rats.
- Untreated old rats showed increased oxidative damage and mitochondrial dysfunction.
- IGF-II treatment reduced activation of apoptotic pathways in aging rats.
Takeaway
This study shows that a hormone called IGF-II can help fix broken parts of cells in older rats, making them work better and healthier.
Methodology
The study involved three groups of rats: young controls, untreated old rats, and old rats treated with IGF-II for 30 days, measuring various mitochondrial functions.
Participant Demographics
Healthy male Wistar rats aged 17 weeks (young controls) and 103 weeks (old rats).
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website